Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 11—November 2005
Research

Toscana Virus in Spain

Sara Sanbonmatsu-Gámez*1, Mercedes Pérez-Ruiz*1, Ximena Collao†, María Paz Sánchez-Seco†, Francisco Morillas-Márquez‡, Manuel de la Rosa-Fraile*, José María Navarro-Marí*, and Antonio Tenorio†
Author affiliations: *Hospital Universitario Virgen de las Nieves, Granada, Spain; †Instituto de Salud Carlos III, Madrid, Spain; ‡Universidad de Granada, Granada, Spain

Main Article

Figure 1

Upper map, geographic situation of the study population (Granada province) in Spain; lower, distribution of geographic areas in Granada province for the seroprevalence study of anti–Toscana virus immunoglobulin G antibodies.

Figure 1. Upper map, geographic situation of the study population (Granada province) in Spain; lower, distribution of geographic areas in Granada province for the seroprevalence study of anti–Toscana virus immunoglobulin G antibodies.

Main Article

1Contributed equally to this work.

Page created: February 17, 2012
Page updated: February 17, 2012
Page reviewed: February 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external